North America Dermatology Treatment Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Exemple de rapport gratuitExemple de rapport gratuit Renseignez-vous avant d'acheterRenseignez-vous avant Acheter maintenantAcheter maintenant

North America Dermatology Treatment Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

  • Healthcare
  • Upcoming Reports
  • Apr 2025
  • North America
  • 350 Pages
  • Nombre de tableaux : 220
  • Nombre de figures : 60
  • Author : Sachin Pawar

North America Dermatology Treatment Devices Market

Taille du marché en milliards USD

TCAC :  % Diagram

Chart Image USD 1.80 Billion USD 3.60 Billion 2024 2032
Diagram Période de prévision
2025 –2032
Diagram Taille du marché (année de référence)
USD 1.80 Billion
Diagram Taille du marché (année de prévision)
USD 3.60 Billion
Diagram TCAC
%
Diagram Principaux acteurs du marché
  • Becton
  • Dickinson and Company (BD)
  • F. Hoffmann-La Roche Ltd.
  • Terumo Corporation
  • B. Braun Melsungen AG

North America Dermatology Treatment Devices Market Segmentation, by type (Push Button Safety Lancet, Pressure Activated Safety Lancet, Side Button Safety Lancet), by application (Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing), by end user (Hospitals & Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics, Others)- Industry Trends and Forecast to 2032

North America Dermatology Treatment Devices Market

 North America Dermatology Treatment Devices Market Size

  • The North America Dermatology Treatment Devices Market was valued atUSD1.8 Billionin 2024and is expected to reachUSD3.6 Billionby 2032
  • During the forecast period of 2025 to 2032 the market is likely to grow at aCAGR of 8.9%,primarily driven by the increasing prevalence of chronic diseases
  • Key drivers of the North America Dermatology Treatment Devices Market include the rising prevalence of chronic diseases like diabetes, growing awareness of needle-stick injuries, and the demand for safer and more efficient blood sampling devices.

North America Dermatology Treatment Devices Market Analysis

  • The increasing focus on minimizing needle-stick injuries in healthcare settings is driving the adoption of safety lancets as a safer alternative for blood sampling.
  • The rise in chronic diseases, especially diabetes, is fueling the demand for blood glucose monitoring devices, including safety lancets, for at-home and clinical use.
  • For instance, Innovations in lancet design, such as push-button mechanisms and pressure-activated features, are enhancing user comfort and safety, further contributing to market growth..
  • Increasing awareness regarding safe and hygienic blood sampling techniques in both medical and home care settings is promoting the use of safety lancets.
  • As healthcare infrastructure improves, especially in developing regions, the demand for advanced medical devices, including safety lancets, is expected to rise significantly.

Report Scope and North America Dermatology Treatment Devices Market Segmentation

Attributes

North America Dermatology Treatment Devices Market Insights

Segments Covered

  • Type:Push Button Safety Lancet, Pressure Activated Safety Lancet, Side Button Safety Lancet
  • Application:Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing
  • end user:Hospitals & Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics, Others

Countries Covered

North America

  • U.S.
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • U.K.
  • Netherlands
  • Switzerland
  • Belgium
  • Russia
  • Italy
  • Spain
  • Turkey
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of Asia-Pacific

Middle East and Africa

  • Saudi Arabia
  • U.A.E.
  • South Africa
  • Egypt
  • Israel
  • Rest of Middle East and Africa

South America

  • Brazil
  • Argentina
  • Rest of South America

Key Market Players

  • Becton, Dickinson and Company (BD)
  • F. Hoffmann-La Roche Ltd.
  • Terumo Corporation
  • B. Braun Melsungen AG
  • HTL-STREFA S.A.
  • Sarstedt AG & Co. KG
  • Greiner Bio-One International GmbH
  • Ypsomed AG
  • Improve Medical Technology Co. Ltd.
  • Nipro Corporation

Market Opportunities

  • Expansion of Home Healthcare and Remote Monitoring
  • Technological Advancements and Product Innovation

Value Added Data Infosets

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.

North America Dermatology Treatment Devices Market Trends

“integration of smart technology and connectivity features”

  • Enhanced Patient Monitoring and Data Collection: Smart safety lancets are equipped with features like integrated biosensors and Bluetooth connectivity, enabling real-time data transmission to digital health platforms. This facilitates continuous monitoring of blood parameters and supports proactive healthcare interventions. ​
  • Improved Patient Compliance and Engagement: By connecting to mobile applications, these devices provide users with reminders, usage statistics, and health insights, thereby encouraging regular testing and adherence to treatment plans. ​
  • Support for Remote Healthcare Services: The integration of smart technology aligns with the growing demand for telemedicine and home healthcare services, allowing healthcare providers to remotely monitor patients' health status and make informed decisions without the need for in-person visits.

North America Dermatology Treatment Devices Market Dynamics

Driver

“rising prevalence of chronic diseases”

  • Increased Demand for Regular Blood Sampling: Chronic diseases require frequent blood tests to monitor parameters like glucose levels, cholesterol, and hemoglobin, leading to a higher need for safe and efficient blood sampling devices.​
  • Enhanced Patient Safety and Compliance: Safety lancets are designed to minimize the risk of needlestick injuries and cross-contamination, encouraging patients to adhere to regular testing schedules.
  • Alignment with Healthcare Regulations: The adoption of safety lancets supports healthcare facilities in complying with stringent safety standards and infection control protocols, promoting their widespread use in clinical settings.

Opportunity

“development of sustainable and eco-friendly safety lancets”

  • Environmental Impact Reduction: With increasing global emphasis on sustainability, manufacturers are innovating safety lancets using biodegradable materials and recyclable packaging to minimize medical waste.
  • Regulatory Compliance and Market Demand: Adhering to environmental regulations and responding to consumer demand for eco-conscious products can enhance brand reputation and market share.
  • Alignment with Healthcare Sustainability Goals: Integrating sustainable practices in product development aligns with the broader healthcare industry's shift towards greener solutions, potentially opening new market segments and partnerships.

Restraint/Challenge

“high cost of advanced lancet technologies”

  • Increased Production Costs: Advanced safety lancets often incorporate features like adjustable penetration depths and ergonomic designs, which enhance user comfort and safety but also increase manufacturing expenses. ​
  • Limited Accessibility in Developing Regions: The elevated costs of these advanced devices can make them less accessible in developing countries, where healthcare budgets are constrained, and cost-effective alternatives are preferred.

North America Dermatology Treatment Devices Market Scope

The market is segmented on the basis application, type, and  end user.

Segmentation

Sub-Segmentation

By Application

  • Blood Glucose Testing
  • Hemoglobin Testing
  • Cholesterol Testing
  • Coagulation Testing

By Type

  • Push Button Safety Lancet
  • Pressure Activated Safety Lancet
  • Side Button Safety Lancet

By End User

  • Hospitals & Clinics
  • Diagnostic Centers and Pathology Laboratories
  • Home Diagnostics
  • Others

North America Dermatology Treatment Devices Market Regional Analysis

“North America is the Dominant Region in the North America Dermatology Treatment Devices Market”

  • High Prevalence of Chronic Diseases: The region exhibits a significant incidence of chronic conditions like diabetes, cardiovascular diseases, and cancer. For instance, in the United States, approximately 6 out of 10 adults have at least one chronic disease, necessitating regular blood sampling for management and monitoring.​
  • Robust Healthcare Infrastructure and Reimbursement Policies: North America boasts advanced healthcare facilities and favorable reimbursement policies, facilitating the adoption of safety lancets. In Canada, initiatives such as the Disability Tax Credit for insulin users underscore the region's commitment to supporting individuals with chronic conditions
  • Technological Advancements and Market Growth: The region is witnessing continuous innovation in safety lancet technologies, including features like adjustable penetration depths and ergonomic designs. This progression, coupled with a substantial patient base and increasing healthcare expenditure, positions North America to account for a significant share of the market's growth

“Asia-Pacific is Projected to Register the Highest Growth Rate in the North America Dermatology Treatment Devices Market”

  • High Prevalence of Diabetes: Over 60% of the Asian population is living with diabetes, with China and India accounting for nearly half of this number. The Western Pacific region alone has more than 138.2 million people with diabetes, a number expected to rise to 201.8 million by 2035. This surge in diabetic cases necessitates frequent blood sampling, driving demand for safety lancets. ​
  • Government Initiatives Promoting Screening: Countries like India and China are implementing large-scale health initiatives to combat chronic diseases. For instance, India's Union Health Ministry launched a program in 2023 aiming to screen 75 million people for hypertension and diabetes by 2025. Similarly, China's 'Healthy China 2030' initiative focuses on integrated diabetes management across urban and rural areas, further increasing the need for diagnostic tools like safety lancets.
  • Advancements in Healthcare Infrastructure: Rapid urbanization and improvements in healthcare services across Asia-Pacific are enhancing access to medical diagnostics. The rising incidence of infectious diseases, such as malaria, dengue, and chikungunya, which require diagnostic testing, is also contributing to the increased demand for safety lancets in the region.

North America Dermatology Treatment Devices Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

  • F. Hoffmann-La Roche Ltd
  • Becton, Dickinson and Company (BD)
  • Terumo Medical Corporation
  • Bayer AG
  • HTL-STREFA S.A.
  • Sarstedt AG & Co. KG
  • Improve Medical Technology Co. Ltd
  • Ypsomed AG
  • Greiner Bio-One International GmbH
  • Owen Mumford Ltd
  • Smiths Medical
  • Nipro Corporation
  • Cardinal Health, Inc.
  • Arkray Inc.
  • Medline Industries, Inc.

Latest Developments in North America Dermatology Treatment Devices Market

  • In 2021, FUJIFILM Corporation opened NURA, a medical screening center focusing on cancer screening in Bangalore, India. This medical screening center is operated by FUJIFILM DKH LLP (FUJIFILM DKH) and Dr. Kutty’s Healthcare (DKH). FUJIFILM DKH LLP (FUJIFILM DKH) is a joint venture of FUJIFILM and Dr. Kutty’s Healthcare (DKH), which runs hospitals and screening centers in India and the Middle East.
  • In 2023, Astellas Pharma announced that it has entered into an agreement with Roche Diabetes Care Japan Co., Ltd. for the development and commercialization of Roche Diabetes Care’s world-renowned Accu-Chek Guide Me blood glucose monitoring system with advanced accuracy as a combined medical product with BlueStar. 

SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

Questions fréquemment posées

Le marché est segmenté en fonction de Segmentation, by type (Push Button Safety Lancet, Pressure Activated Safety Lancet, Side Button Safety Lancet), by application (Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing), by end user (Hospitals & Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics, Others)- Industry Trends and Forecast to 2032 .
La taille du North America Dermatology Treatment Devices Market était estimée à 1.80 USD Billion USD en 2024.
Le North America Dermatology Treatment Devices Market devrait croître à un TCAC de 8.9% sur la période de prévision de 2025 à 2032.
Les principaux acteurs du marché sont Becton, Dickinson and Company (BD), F. Hoffmann-La Roche Ltd., Terumo Corporation, B. Braun Melsungen AG, HTL-STREFA S.A.
Le rapport couvre les données de North America.
Testimonial